TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
IMMX

Immix Biopharma Inc

Healthcare · Biotechnology

11.50$ +4.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMMX
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
99.0% 98.6% 100.0% 99.9% 99.3% 88.0% 96.6%
77.8% 72.5% 97.0% 90.1% 87.9% 77.1% 89.6%
77.8% 72.5% 97.0% 90.1% 87.9% 77.1% 95.8%
18.6% 23.6% 0.1% 1.7% 5.9% 8.6% –
1.0% 1.4% 0.0% 0.0% – – –
486.7% 976.7% 1.1% 11.7% 18.7% 42.3% 10.5%
486.7% 976.7% 1.1% 8.5% 18.7% 37.9% 9.6%
434.8% 759.8% 0.3% – – 0.3% 0.1%
26.3% 46.8% 0.8% 1.0% 7.2% 23.5% 5.2%
-386.7% -876.7% 98.9% 88.3% 82.3% 57.7% 89.5%
-447.9% -995.5% -163.6% -254.8% -268.1% -326.9% -99.6%
357.9% 1,440.7% 20.2% 93.2% 87.0% 123.3% 31.4%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?